Literature DB >> 1328523

Noncompetitive inhibition of N-methyl-D-aspartate by conantokin-G: evidence for an allosteric interaction at polyamine sites.

P Skolnick1, K Boje, R Miller, M Pennington, M L Maccecchini.   

Abstract

Conantokins T and G are polypeptide toxins present in snails of the genus Conus. These substances were recently reported to act as N-methyl-D-aspartate (NMDA) antagonists. In the present study, we examined the possible mechanisms producing this antagonism. Conantokin-G inhibited spermine- and spermidine-stimulated [3H]MK-801 binding to extensively washed rat forebrain membranes in a noncompetitive manner with IC50 values of approximately 507 and approximately 946 nM, respectively. In contrast, glutamate-enhanced [3H]MK-801 binding was unaffected by conantokin-G concentrations of less than or equal to 20 microM. At concentrations greater than or equal to 5 microM, conantokin-G effected a modest, noncompetitive inhibition of glycine-stimulated [3H]MK-801 binding and also produced a small enhancement of basal [3H]MK-801 binding. Conantokin-G reduced (IC50 approximately 1.08 microM) the NMDA-stimulated accumulation of cyclic GMP in cerebellar granule cell cultures to basal values, but did not affect kainate-mediated increases in cyclic GMP. These findings indicate that conantokin-G acts as a noncompetitive NMDA antagonist through an allosteric inhibition of polyamine responses. The neurochemical profile of this polypeptide is distinct from previously described noncompetitive NMDA antagonists.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1328523     DOI: 10.1111/j.1471-4159.1992.tb08468.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  6 in total

1.  Opposing action of conantokin-G on synaptically and extrasynaptically-activated NMDA receptors.

Authors:  Rashna Balsara; Neill Li; Danielle Weber-Adrian; Louxiu Huang; Francis J Castellino
Journal:  Neuropharmacology       Date:  2012-01-27       Impact factor: 5.250

Review 2.  The role of group I metabotropic glutamate receptors in neuronal excitotoxicity in Alzheimer's disease.

Authors:  Vicky W-W Tsai; Heather L Scott; Richard J Lewis; Peter R Dodd
Journal:  Neurotox Res       Date:  2005       Impact factor: 3.911

3.  Metal-ion-binding properties of synthetic conantokin-G.

Authors:  T Blandl; J Zajicek; M Prorok; F J Castellino
Journal:  Biochem J       Date:  1997-12-15       Impact factor: 3.857

4.  Studies on neuronal apoptosis in primary forebrain cultures: neuroprotective/anti-apoptotic action of NR2B NMDA antagonists.

Authors:  Jitendra R Dave; Anthony J Williams; John R Moffett; Michael L Koenig; Frank C Tortella
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

Review 5.  Neuroprotective and cardioprotective conopeptides: an emerging class of drug leads.

Authors:  Vernon D Twede; George Miljanich; Baldomero M Olivera; Grzegorz Bulaj
Journal:  Curr Opin Drug Discov Devel       Date:  2009-03

6.  A Conantokin Peptide Con-T[M8Q] Inhibits Morphine Dependence with High Potency and Low Side Effects.

Authors:  Zhuguo Liu; Zheng Yu; Shuo Yu; Cui Zhu; Mingxin Dong; Wenxiang Mao; Jie Hu; Mary Prorok; Ruibin Su; Qiuyun Dai
Journal:  Mar Drugs       Date:  2021-01-19       Impact factor: 5.118

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.